An outbreak of hepatitis A among homeless drug users in Rotterdam, The Netherlands

Journal of Medical Virology - Tập 77 Số 3 - Trang 360-366 - 2005
Grace Tjon1, Hannelore M Götz2, Alex Koek1, Onno de Zwart2, P. L. J. M. Mertens2, R A Coutinho3,1, Sylvia M. Bruisten1
1Municipal Health Service of Amsterdam (Streeklaboratorium voor de Volksgezondheid), Nieuwe Achtergracht 100, Amsterdam, The Netherlands
2Municipal Health Service of Rotterdam, AIZ, Schiedamsedijk 95, Rotterdam, The Netherlands
3Academic Medical Center, Department of Human Retrovirology, Amsterdam, Meibergdreef 15, Amsterdam, The Netherlands

Tóm tắt

Abstract

From the end of January to mid‐June 2004 (weeks 5–24) a hepatitis A virus (HAV) outbreak occurred among a homeless and drug user community in Rotterdam, The Netherlands. To prevent further spread of the virus within this group and to the general population, the Municipal Health Service of Rotterdam organized a mass vaccination campaign during which 83% (1,515/1,800) of the homeless people were vaccinated. As part of a national HAV typing study, blood and/or fecal samples of 30 Rotterdam HAV IgM(+) patients who fell ill during the period of 1 September 2003–1 December 2004 were tested. The tests included RT‐PCR and sequencing at the VP3‐VP1 and VP1‐P2a regions of the HAV genome. It was found that 12 homeless people, one family member of a homeless person and two people without a known risk were infected with a unique subtype 3a strain. Four of the homeless patients became ill after vaccination and were probably infected at the time. This study shows that Dutch homeless people and drug users involved in HAV outbreaks should be offered HAV vaccine actively to prevent further spread of the infection. Furthermore, it was shown by molecular techniques that the unique subtype 3a strain was not found before the Rotterdam outbreak or afterwards, indicating that the mass vaccination campaign was successful. J. Med. Virol. 77:360–366, 2005. © 2005 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1002/1096-9071(20000201)63:2<88::AID-JMV1001>3.0.CO;2-G

10.1086/339683

Crowcroft NS, 2003, Hepatitis A virus infections in injecting drug users, Commun Dis Public Health, 6, 82

10.1159/000149367

HallTA.1999.BioEdit: A user‐friendly biological sequence alignment editor and analysis. Ref Type: Computer Program.

KumarS TamuraK JakobsenIB NeiM.2001.MEGA2: Molecular evolutionary genetics analysis software Arizona State University Tempe Arizona USA. Ref Type: Computer Program.

10.3109/00365549709019029

10.1093/infdis/148.6.1033

10.1099/vir.0.80304-0

MacGregor A, 1983, Monoclonal antibodies against hepatitis A virus, J Clin Microbiol, 18, 1237, 10.1128/jcm.18.5.1237-1243.1983

10.7326/0003-4819-120-1-199401010-00001

MarkkuKuusi PekkaNuorti TimoRostila CamillaJokinen.2003.Hepatitis A infections in intravenous drug users Finland 2002. Eurosurveillance Weekly 7.

10.1001/archpedi.1996.02170320079014

10.1017/S0950268801006185

Perrett K, 2003, Changing epidemiology of hepatitis A: Should we be doing more to vaccinate injecting drug users?, Commun Dis Public Health, 6, 97

10.1093/infdis/163.2.286

10.1099/0022-1317-73-6-1365

10.1111/j.1365-2893.2004.00503.x

10.1080/003655498750002277

Stene‐Johansen K, 1999, Surveillance of hepatitis A by molecular epidemiologic studies, Tidsskr Nor Laegeforen, 119, 3725

10.1097/00042737-200308000-00011

10.1002/jmv.10377

10.1017/S0950268899003842

10.1016/j.jcv.2004.03.008

Van Der Eerden LJ, 2004, Surveillance of hepatitis A in The Netherlands 1993–2002, Ned Tijdschr Geneeskd, 148, 1390

10.1086/381152

10.1016/S0264-410X(02)00042-7